Iterum Therapeutics PLC
NASDAQ:ITRM

Watchlist Manager
Iterum Therapeutics PLC Logo
Iterum Therapeutics PLC
NASDAQ:ITRM
Watchlist
Price: 0.9318 USD 0.08% Market Closed
Market Cap: 32.2m USD

Intrinsic Value

ITRM doesn't have a meaningful market cap.

There is not enough data to reliably calculate the intrinsic value of ITRM.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ITRM Intrinsic Value
Not Available
Base Case Scenario

Fundamental Analysis

Company Overview
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Iterum Therapeutics PLC
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Iterum Therapeutics PLC

Current Assets 13.5m
Cash & Short-Term Investments 12.7m
Receivables 19k
Other Current Assets 842k
Non-Current Assets 19.5m
PP&E 37k
Intangibles 19.4m
Other Non-Current Assets 21k
Efficiency

Free Cash Flow Analysis
Iterum Therapeutics PLC

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Iterum Therapeutics PLC

Revenue
0 USD
Cost of Revenue
-596k USD
Gross Profit
-596k USD
Operating Expenses
-15.6m USD
Operating Income
-16.2m USD
Other Expenses
-6.3m USD
Net Income
-22.6m USD
Fundamental Scores

ITRM Profitability Score
Profitability Due Diligence

Iterum Therapeutics PLC's profitability score is 49/100. The higher the profitability score, the more profitable the company is.

49/100
Profitability
Score

Iterum Therapeutics PLC's profitability score is 49/100. The higher the profitability score, the more profitable the company is.

ITRM Solvency Score
Solvency Due Diligence

Iterum Therapeutics PLC's solvency score is 51/100. The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Long-Term Solvency
Positive Net Debt
51/100
Solvency
Score

Iterum Therapeutics PLC's solvency score is 51/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ITRM Price Targets Summary
Iterum Therapeutics PLC

Wall Street analysts forecast ITRM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ITRM is 5.1 USD with a low forecast of 5.05 USD and a high forecast of 5.25 USD.

Lowest
Price Target
5.05 USD
442% Upside
Average
Price Target
5.1 USD
447% Upside
Highest
Price Target
5.25 USD
463% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Iterum Therapeutics PLC
does not pay dividends
Shareholder Yield

Current shareholder yield for ITRM is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

ITRM Insider Trading
Buy and sell transactions by insiders